| Galectins in cancer: carcinogenesis, diagnosis and therapy AH Ebrahim, Z Alalawi, L Mirandola, R Rakhshanda, S Dahlbeck, ... Annals of translational medicine 2 (9), 2014 | 125 | 2014 |
| Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1 L Mirandola, L Apicella, M Colombo, Y Yu, DG Berta, N Platonova, ... Leukemia 27 (7), 1558-1566, 2013 | 103 | 2013 |
| Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy JA Figueroa, A Reidy, L Mirandola, K Trotter, N Suvorava, A Figueroa, ... International reviews of immunology 34 (2), 154-187, 2015 | 102 | 2015 |
| Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes M Colombo, L Mirandola, N Platonova, L Apicella, A Basile, AJ Figueroa, ... Leukemia 27 (5), 1009-1018, 2013 | 99 | 2013 |
| Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer L Mirandola, M J. Cannon, E Cobos, G Bernardini, MR Jenkins, WM Kast, ... International reviews of immunology 30 (2-3), 127-137, 2011 | 84 | 2011 |
| Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma L Mirandola, Y Yu, K Chui, MR Jenkins, E Cobos, CM John, ... PloS one 6 (7), e21811, 2011 | 78 | 2011 |
| Notch1 regulates chemotaxis and proliferation by controlling the CC‐chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia L Mirandola, M Chiriva‐Internati, D Montagna, F Locatelli, M Zecca, ... The Journal of pathology 226 (5), 713-722, 2012 | 75 | 2012 |
| Notch signaling drives multiple myeloma induced osteoclastogenesis M Colombo, K Thümmler, L Mirandola, S Garavelli, K Todoerti, L Apicella, ... Oncotarget 5 (21), 10393, 2014 | 68 | 2014 |
| The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review C Cobos, JA Figueroa, L Mirandola, M Colombo, G Summers, A Figueroa, ... International reviews of immunology 33 (5), 383-401, 2014 | 64 | 2014 |
| Identification of AKAP‐4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer M Chiriva‐Internati, Y Yu, L Mirandola, N D'Cunha, F Hardwicke, ... The Prostate 72 (1), 12-23, 2012 | 64 | 2012 |
| Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer M Chiriva-Internati, Y Yu, L Mirandola, MR Jenkins, C Chapman, ... PloS one 5 (5), e10471, 2010 | 60 | 2010 |
| Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer L Mirandola, Y Yu, MJ Cannon, MR Jenkins, RL Rahman, DD Nguyen, ... Gynecologic oncology 135 (3), 573-579, 2014 | 57 | 2014 |
| Cancer cells exploit notch signaling to redefine a supportive cytokine milieu M Colombo, L Mirandola, M Chiriva-Internati, A Basile, M Locati, E Lesma, ... Frontiers in immunology 9, 380699, 2018 | 54 | 2018 |
| Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium L Mirandola, R Wade, R Verma, C Pena, N Hosiriluck, JA Figueroa, ... International Reviews of Immunology 34 (2), 134-142, 2015 | 50 | 2015 |
| Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets L Mirandola, JA Figueroa, TT Phan, F Grizzi, M Kim, RL Rahman, ... Oncotarget 6 (5), 2812, 2015 | 50 | 2015 |
| Notch-ing from T-cell to B-cell lymphoid malignancies L Mirandola, P Comi, E Cobos, WM Kast, M Chiriva-Internati, ... Cancer letters 308 (1), 1-13, 2011 | 44 | 2011 |
| Application of vitamin D and derivatives in hematological malignancies M Kim, L Mirandola, A Pandey, DD Nguyen, MR Jenkins, M Turcel, ... Cancer letters 319 (1), 8-22, 2012 | 40 | 2012 |
| Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapy M Chiriva-Internati, L Mirandola, Y Yu, MR Jenkins, R Gornati, ... Journal of Immunotherapy 34 (6), 490-499, 2011 | 38 | 2011 |
| Aging, cancer, and cancer vaccines P Mazzola, S Radhi, L Mirandola, G Annoni, M Jenkins, E Cobos, ... Immunity & Ageing 9, 1-11, 2012 | 36 | 2012 |
| Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer? L Mirandola, DD Nguyen, RL Rahman, F Grizzi, Y Yuefei, JA Figueroa, ... International reviews of immunology 33 (5), 417-427, 2014 | 34 | 2014 |
